- REGULATED
- TEMPERATURE-CONTROLLED
- FASTER
Our Process of Named Patient Programs
Named Patient Programs (NPPs) offer regulated access to medications before they receive official approval in a patient’s home country. Physicians can request these medicines on behalf of specific patients who have a genuine, unmet medical need. This access applies to medicines in late-stage clinical trials or those approved in other countries. Through NPPs, patients can obtain these medications before they are licensed locally.
Branding & Digital Team
Awareness
Partecipating Awareness Programs With Patient Support Socity & Government
informations
Sharing Information Of Rare Disease Management And Drug Access To Medical Community.
Medical Marketing
Participating Scientific Sessions Related To Rare Disease All Segments.
In our operational framework, we adhere to pharmaceutically validated channels, strictly in line with WHO Good Distribution Practices.
Our Named Patient Programs encompass a wide range of medicines, including but not limited to:
- 1. Discontinued and orphan drugs
- 2. Medicines utilized in oncology
- 3. Medicinal products unlicensed in the destination country
If you have any inquiries about a specific medicine or product, kindly complete the form provided. Rest assured, our team will promptly respond to your query.
